• Users Online: 891
  • Home
  • Print this page
  • Email this page
Home Current issue Archives Ahead of print Search Subscribe Instructions Submit article About us Editorial board Contacts Login 
ORIGINAL ARTICLE
Year : 2012  |  Volume : 33  |  Issue : 1  |  Page : 15-18

The role of the brain-derived neurotrophic factors in the progression of bipolar disorders


1 Department of Psychiatry, Faculty of Medicine, Cairo University, Cairo, Egypt
2 Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt

Correspondence Address:
Heba Fathy
Department of Psychiatry, Faculty of Medicine, Cairo University, Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7123/01.EJP.0000411123.49083.e0

Rights and Permissions

Introduction

Bipolar disorder (BPD) is considered to be the most prevalent psychiatric conditions, and is also among the most severe and debilitating. It was suggested that the brain-derived neurotrophic factor (BDNF) plays an important role in the pathophysiology of mood disorders. BDNF appears to be an unspecific biomarker of neuropsychiatric disorders characterized by neurodegenerative changes.

Aim

The aim of the study was to investigate the association between BDNFs and progression of BPDs.

Participants and methods

After receiving approval from the ethical committee in kasr El Eini hospital, 80 participants were randomly selected in a comparative cross sectional study. The sample consisted of two groups: a group of patients with BPDs (n=40), including patients with manic, depressive, mixed episode, or in remission, and a control group (n=40). The patients were recruited from the psychiatric outpatient clinic. Patients were diagnosed by a lecturer of psychiatry according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria. Psychometric procedure: the Hamilton rating scale of depression and the Young Mania Rating Scale were used: laboratory: Radio-immune assay of BDNFs was carried out.

Results

Fifty-five percent of the patients in the bipolar group had three or more episodes. There was a statistically significant difference between the cases and the controls in the level of BDNF. There was a negative correlation between the BDNF and the number of episodes (P=0.000) and there was also a negative correlation between BDNF and disease duration (P=0.000). There were no correlations between BDNF and the diagnosis of BPD (P=0.3).

Conclusion

BDNF was lower than normal in bipolar patients and this was correlated with the number of episodes and duration of disease.



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1365    
    Printed55    
    Emailed0    
    PDF Downloaded72    
    Comments [Add]    

Recommend this journal